Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Fluspirilene is a dopamine D2 and D3 receptor antagonist (Kis = 1.5 and 1.1 nM, respectively).1 It is selective for dopamine D2 and D3 receptors over dopamine D1, α1- and α2-adrenergic, H1 histamine, and sigma-1 (σ1) receptors (Kis = 450, 102, >5,000, 540, and 150 nM, respectively), muscarinic acetylcholine receptors (mAChRs; Ki = >5,000 nM), and the serotonin (5-HT) receptor subtypes 5-HT1A, 5-HT1B, 5-HT2C, and 5-HT3 (Kis = 110, >5,000, 1,830, and >5,000 nM, respectively). Fluspirilene is also a noncompetitive inhibitor of L-type calcium (Cav1) channels with an IC50 value of 30 nM.2 It inhibits apomorphine-induced vomiting in dogs (ED50 = 0.011 mg/kg).3 Formulations containing fluspirilene have been used in the treatment of schizophrenia.
WARNING This product is not for human or veterinary use.
1. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology (Berl) 124(1-2), 57-73 (1996).
2. Selective antagonism of calcium channel activators by fluspirilene. Br. J. Pharmacol. 100(2), 211-216 (1990).
3. Pharmacology of fluspirilene (R 6218) [8-